Menu
Recruiting NCT05721261

Regeneration of Acutely Injured Nerves With Temporary Electrical Stimulation

No phase Interventional Nerve Injury

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Temporary Peripheral Nerve Stimulation System, Sham Temporary Peripheral Nerve Stimulation System.
Who it may be relevant to
Registry conditions: Nerve Injury. Basic parameters: 18 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States, Canada
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

A novel temporary peripheral nerve stimulation system that delivers a single dose of electrical stimulation therapy for 1 hour will be evaluated for safety and effectiveness.

Interventions

  • Device Temporary Peripheral Nerve Stimulation System
    Single use medical device. Therapy consists of single, 1 hour dose of electrical stimulation delivered proximal to injury site.
  • Device Sham Temporary Peripheral Nerve Stimulation System
    Single use medical device. Sham treatment consists of single, 1 hour dose of sham stimulation.

Primary outcome measures

  • Sensory recovery [Time frame: 6 months]
  • Cumulative incidence of adverse events [Time frame: 6 months]

Eligibility criteria

Inclusion criteria

  • Peripheral nerve injury

Exclusion criteria

  • Peripheral neuropathy
  • Patients with any active implanted device

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Double blind
Primary purpose
Treatment

Study locations

Canada · 9 centers
  • University of Alberta Hospital — Edmonton
  • Saint John Regional Hospital — Saint John
  • Hamilton General Hospital — Hamilton
  • St. Joseph's Healthcare Hamilton — Hamilton
  • Roth | McFarlane Hand & Upper Limb Centre — London
  • Southlake Health — Newmarket
  • Humber River Health — Toronto
  • North York General Hospital — Toronto
  • … and 1 more center
United States · 6 centers
  • University of Florida Health — Gainesville
  • Orlando Health Jewett Orthopedic Institute — Orlando
  • Louisiana State University Health Sciences Center — New Orleans
  • The Curtis National Hand Center — Baltimore
  • WellSpan Health — York
  • John Peter Smith Hospital — Fort Worth

Identifiers

NCT: NCT05721261 · EPNR-CIP-002

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗